Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

U.S. Surgical/Progressive Angioplasty Systems' Paragon coronary stent to launch in Europe in October.

This article was originally published in The Gray Sheet

Executive Summary

U.S. SURGICAL/PROGRESSIVE ANGIOPLASTY SYSTEMS PARAGON CORONARY STENT is slated for an October European launch, assuming CE mark clearance in the next few weeks, USSC says. U.S. Surgical gained the stent through the Sept. 22 acquisition of Progressive Angioplasty Systems, which will provide USSC an entry into the percutaneous transluminal coronary angioplasty and stent markets.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT008869

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel